Streamline Health Solutions, Inc., provider of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimization for healthcare enterprises, announced the hiring of Thomas (Tom) J. Gibson as Senior Vice President and Chief Financial Officer for the Company, effective September 10, 2018. 

Mr. Gibson, 55, is the former Chief Financial Officer of Citra Health Solutions and Vivex Biomedical, Inc. Prior to his service with Citra, Mr. Gibson served as the Principal Accounting Officer, Senior Vice President of Finance and Corporate Controller at R1 RCM (previously Accretive Health, Inc.).  Mr. Gibson previously served with Greenway Medical Technologies as Chief Accounting Officer and with MedAssets as Senior Vice President, Finance and before that as Vice President of Revenue Cycle Management. Mr. Gibson spent the first 15 years of his professional career with Big 4 CPA firms working with both public and private companies.

"We are pleased to have Tom Gibson join our management team as Senior Vice President and Chief Financial Officer," stated David Sides, President and Chief Executive Officer, Streamline Health. "Given Tom's background in accounting with Big 4 firms such as PwC and EY, he is quite accomplished in complicated revenue recognition such as performance-based contracts in healthcare and software.  We look forward to his contributions, specifically inside the Company focusing on funding revenue growth, and outside the Company working more directly with the investor community."

"I am very excited about the growth opportunities at Streamline Health and believe that I am joining the company at a very good time in its lifecycle," Mr. Gibson stated.  "Having spent most of my career in the healthcare industry, specifically in software, and being intimately familiar with Revenue Cycle Management, I think Streamline's solutions and services are very well positioned in the middle of a healthcare providers' revenue cycle.  I want to help orchestrate strategies focused on revenue growth while continuing to successfully manage costs to help increase cash flow."

In connection with his employment, the Company intends to grant equity awards to Mr. Gibson on the effective date of his employment, including 100,000 restricted stock units, which are expected to be granted outside of the Company's Amended and Restated 2013 Stock Incentive Plan. Additionally, the Company will grant to Mr. Gibson, effective as of February 1, 2019, an additional 50,000 restricted stock units. The restricted stock units will vest in three substantially equal annual installments over the first three years of employment. The grants were approved by the Compensation Committee of the Board of Directors and were granted as an inducement material to Mr. Gibson's entering into employment with the Company in reliance on Nasdaq Listing Rule 5635(c)(4), which requires this public announcement.